InflaRx

YTD

ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell InflaRx and other ETFs, options, and stocks.

About IFRX

InflaRx NV is a clinical-stage biopharmaceutical company, which engages in the discovery and development of inhibitors of the complement activation factor known as C5a and its receptor C5aR. Its primary product candidate is Vilobelimab.

CEO

Niels Christoph Riedemann

CEONiels Christoph Riedemann

Employees

Employees66

Headquarters

Jena, Thueringen

HeadquartersJena, Thueringen

Founded

2007

Founded2007

Employees

Employees66

IFRX Key Statistics

Market cap

78.31M

Market cap78.31M

Price-Earnings ratio

-1.63

Price-Earnings ratio-1.63

Dividend yield

—

Dividend yield—

Average volume

150.96K

Average volume150.96K

High today

$1.43

High today$1.43

Low today

$1.28

Low today$1.28

Open price

$1.39

Open price$1.39

Volume

169.30K

Volume169.30K

52 Week high

$5.20

52 Week high$5.20

52 Week low

$1.14

52 Week low$1.14

IFRX News

TipRanks 23h

InflaRx N.V. Announces Share Capital Amendment - TipRanks.com - TipRanks

Inflarx N.V. (IFRX) has released an update. InflaRx N.V., a Dutch-based public limited liability company, has announced a partial amendment to its Articles of...